IRVING, Texas, July 13 /PRNewswire-FirstCall/ -- Carrington Laboratories, Inc. today announced it has expanded its international product line distribution network with the recent signing of two sales distribution agreements.
The Boushahri Group, WLL, of Kuwait will distribute several of the Carrington product lines, including its products for wound care, skin care, oral care, incontinence and dietary supplements, in Kuwait and Iraq. The Kuryapi Company will exclusively distribute Carrington's line of oral care products in Turkey.
Both three-year agreements were finalized in June 2006.
Carrington utilizes naturally-occurring polymeric carbohydrates to manufacture CE marked products for mucositis, radiation dermatitis, wound, and oral care. Brand names include Carrasyn(R)V Hydrogel and CarraSmart(TM) Gel, Foam, and Film for wound dressings, RadiaGel(TM) and RadiaCream(TM) for radiation dermatitis, CarraDerm(TM) and the Carrington(R) line of moisturizing creams, and OraRinse(TM), OraBan(TM) and OraPatch(TM) for mouth irritations.
The Company also manufactures and markets the nutraceutical raw material Manapol(R), derived from the Aloe vera L. plant. Carrington's line of dietary supplements for enhancing the immune system are available in capsule, tablet, liquid and powder form and are marketed under the Manapol(R) brand.
"We are very pleased to have The Boushahri Group and Kuryapi Company join our growing network of international distributors," said Carlton E. Turner, PhD, CEO of Carrington. "Offshore markets are a growing opportunity for our core business unit and these two fine organizations expand our coverage in important geographic areas."
About The Boushahri Group, WLL
Boushahri Group, WLL, founded in 1967, is one of Kuwait's leading diversified corporations. The company's divisions include pharmaceuticals and scientifics, photography and graphics, consumer electronics, telecommunications, fashion and footwear, real estate, industrial chemicals, foods, and building supplies. The Boushahri Group distributes well-known international brands through the company's retail outlets located in various regions of Kuwait. For more information, visit http://www.boushahrigroup.com .
About The Kuryapi Company
Kuryapi Company, located in Adana, Turkey, was founded in 1989. Although specialized in construction, the company launched a health sector enterprise in 2004 and has been building distribution networks. Its health sector has increased market share. Distribution channels are now national and focused on pharmacies, supermarkets, health food stores and end consumers.
About Carrington
Carrington Laboratories, Inc. is an ISO 9001-certified, research-based, biopharmaceutical and consumer products company currently utilizing naturally- occurring complex carbohydrates to manufacture and market products for mucositis, radiation dermatitis, wound and oral care, as well as to manufacture and market the nutraceutical raw material Manapol(R) and cosmetic raw material Hydrapol(TM). Carrington also manufactures and markets consumer products and manufactures quality products for other companies. Manufacturing operations comply with cGMP standards. Carrington's DelSite Biotechnologies subsidiary is developing its proprietary GelSite(R) technology designed to provide controlled release of peptide and protein-based drugs. Carrington's technology is protected by more than 130 patents in 26 countries. Select products carry the CE mark, recognized by more than 20 countries around the world. For more information, visit http://www.carringtonlabs.com .
Certain statements in this release concerning Carrington may be forward- looking. Actual events will be dependent upon a number of factors and risks including, but not limited to: subsequent changes in plans by the Company's management; delays or problems in formulation, manufacturing, distribution, production and/or launch of new finished products; changes in the regulatory process; changes in market trends; and a number of other factors and risks described from time to time in the Company's filings with the Securities & Exchange Commission, including the Form 10-Q filed on May 5, 2006.
Carrington Laboratories, Inc.CONTACT: Carlton E. Turner, Chief Executive Officer of CarringtonLaboratories, Inc., +1-972-518-1300
Web site: http://www.carringtonlabs.com/
